Ladenburg Thalmann Financial Services’s Autolus Therapeutics AUTL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$297K	Buy	+22,500	New	+$295K	﹤0.01%	2208

Other funds holding AUTL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AUTL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Autolus Therapeutics (AUTL) in Q4 2019: 22,500 shares worth $297K. The stake represents ﹤0.01% of the portfolio and ranks #2208 among its holdings.

55 funds tracked by Wall St. Rank hold AUTL as of Q4 2019.

Ladenburg Thalmann Financial Services held 22,500 shares of Autolus Therapeutics worth $297K as of Q4 2019.
Autolus Therapeutics was a new Ladenburg Thalmann Financial Services position in Q4 2019.
Autolus Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2208 holding.
55 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.